What if you could minimize the risk of virus contamination throughout your virus clearance process?
In the Virus Safety Learning Center, you will find guidance and information helpful in resolving many complex manufacturing challenges you face in bringing your biotech- and plasma-derived therapeutics to market.
Here we discuss the decisions you must make in each phase of the virus clearance implementation, providing insight and guidance based upon years of working with the most successful drug manufacturers in the world to ensure successful and robust clearance. Whether your concerns are about government regulations, selecting the best filter, or process-scale implementation, we can help.
Use the work flow links above to navigate to that phase of the virus validation process in which you have the most interest.